ADMA Biologics (ADMA) Stock Price, Quote, News & History | Benzinga

ADMA Biologics Inc (ADMA) Stock Price, Quote, News & History

ADMANASDAQ

Trade with Public

Trade with Public

$9.75

At close: Aug 11, 5:00 PM EST

$9.77

0.020.21%

After Hours: 7:03 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 5th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 6 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 3.50M

Day Range

- - -

52 Wk Range

7.21 - 20.46

Market Cap

$2.19B

P/E Ratio

13.93

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

13.22%

Days to Cover

9.12

Recent ADMA Biologics, Inc. News

Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech

Stanley Druckenmiller cut Amazon, exited Alphabet while increasing bets on Argentina, commodities, semiconductors, biotech stocks during Q1.

Surbhi Jain

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ: FSLY) down 21.6%, and other stocks decline in pre-market trading.

Avi Kapoor

Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket

Shares of Kulicke & Soffa Industries (NASDAQ: VECO) rose after beating earnings estimates. Other gainers include Global Engine, Agilon Health, and Blue Bird Corp.

Avi Kapoor

Leggett & Platt, Allogene Therapeutics, Revolution Medicines And Other Big Stocks Moving Higher On Monday

U.S. stocks were mixed on Monday, with the Dow Jones falling over 200 points. Leggett & Platt rose on news of being acquired by Somnigroup.

Avi Kapoor

Oxford Industries Posts Q4 Results, Joins ADMA Biologics, Vor Biopharma And Other Big Stocks Moving Higher On Friday

U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend. Other gains: AGX 35.5%, MSC 24.5%, ADMA 13%, SGML 12.2%, KOD 10.5%, TBN 9.9%, METC 8.8%, U 8.3%, MEOH 7.7%, VOR 6.8%, Kopin Corp.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

136.72M

Investing Cash Flow (TTM)

-14.50M

Financing Cash Flow (TTM)

-76.49M

Free Cash Flow (TTM)

116.22M

Capital Expenditure (TTM)

-20.50M

Net Change in Cash (TTM)

45.74M

Analyst Trends and Forecast

1

Mar

2

Apr

2

May

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.25B

PE Ratio (TTM)

13.93

PE Ratio (FWD)

12.35

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.56

PB Ratio (TTM)

5.35

Earnings Yield % (TTM)

7.18%

Earnings Yield % (FWD)

8.10%

EV / EBITDA (TTM)

9.66

Price / EBITDA (TTM)

10.03

Price / Free Cash Flow (TTM)

20.10

Book Value / Share

$1.82

Company Debt

Total Debt

$196.59M

LT Debt

$192.84M

LT Debt Issuance (TTM)

$200.00M

LT Debt Repayment (TTM)

-$76.88M

Total Cash

$136.02M

Debt to Equity

0.50

Issuance of Debt (TTM)

$123.12M

Repayment of Debt (TTM)

-$76.88M

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 3.50M

Day Range

- - -

52 Wk Range

7.21 - 20.46

Market Cap

$2.19B

P/E Ratio

13.93

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

13.22%

Days to Cover

9.12

About

Sector

Health Care

Industry

Biotechnology

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk f...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ADMA Biologics (ADMA) stock?

A

You can purchase shares of ADMA Biologics (NASDAQ:ADMA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ADMA Biologics (ADMA) competitors?

A

Other companies in ADMA Biologics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for ADMA Biologics (ADMA) stock?

A

ADMA Biologics has a consensus price target of $23.25.

Q

What is the current price for ADMA Biologics (ADMA)?

A

The stock price for ADMA Biologics (NASDAQ: ADMA) is $9.77 last updated August 10, 2026 at 7:03 PM EDT.

Q

Does ADMA Biologics (ADMA) pay a dividend?

A

There are no upcoming dividends for ADMA Biologics.

Q

When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?

A

ADMA Biologics does not have any upcoming earnings scheduled.

Q

Is ADMA Biologics (ADMA) going to split?

A

There is no upcoming split for ADMA Biologics.

Q

What sector and industry does ADMA Biologics (ADMA) operate in?

A

ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.